Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

A Phase 1, Open-Label, Dose Escalation and Dose Expansion Study of Cln-049 for the Treatment of Acute Myeloid Leukemia Patients with Measurable Residual Disease

Blood (2024) 144 (Supplement 1): 2883.1.

https://doi.org/10.1182/blood-2024-201478

Published: 2024

Journal Articles

Analysis of the Impact of Body Mass Index (BMI) on the Durability of Response in Patients with Aplastic Anemia Treated with Weight-Adjusted Horse Anti-Thymocyte Globulin (hATG)

Jeanette Walter, Benjamin Rolles, Yannic Schumacher, Frauke Theis, Leo Hansmann, Daniel Heudobler, Markus Radsak, Michael Heuser, Julia-Annabell Georgi, Jörg Chromik, Beatrice Drexler, Jörg Schubert, Kim Kricheldorf, Susanne Isfort, Jens Panse, Tim H. Brümmendorf, Fabian Beier

Blood (2023) 142 (Supplement 1): 5641.

https://doi.org/10.1182/blood-2023-183075

Published: 2023

Journal Articles

Mutation Profile of PPM1D and TP53 in Patients with Myelodysplastic Syndromes and Complex Chromosome Abnormalities

Blood (2019) 134 (Supplement_1): 2994.

https://doi.org/10.1182/blood-2019-126778

Published: 2019

Journal Articles

Low-Dose Azacitidine, Pioglitazone and All-Trans Retinoic Acid Versus Standard-Dose Azacitidine in Patients ≥ 60 Years with Acute Myeloid Leukemia Refractory to Standard Induction Chemotherapy (AMLSG 26-16/AML-ViVA): Results of the Safety Run-in Phase I

Daniel Heudobler, Sebastian Klobuch, MD, Florian Lüke, MD, Joachim Hahn, MD, Matthias Grube, MD, Stephan Kremers, MD, Thomas Südhoff, MD, Jörg Westermann, MD, Marie-Luise Huetter-Kroenke, MD, Peter Paschka, MD, Gauthier Bouche, Hartmut Döhner, MD, Wolfgang Herr, MD, Simone Thomas, MD, Albrecht Reichle, MD

Blood (2019) 134 (Supplement_1): 1382.

https://doi.org/10.1182/blood-2019-129977

Published: 2019

Journal Articles

Molecular Profile and Cytomorphological Manifestation of Isolated Y Loss in Myelodysplastic Syndromes

Blood (2018) 132 (Supplement 1): 4358.

https://doi.org/10.1182/blood-2018-99-114216

Published: 2018

Journal Articles

Integrated Analysis of Global DNA Methylation and Transcription Reveals a Leukemia Subtype with Extreme Hypermethylation Associated with Silencing of Regulators of Differentiation

Claudia Gebhard, PhD, Roger Mulet-Lazaro, B.Sc., Lucia Schwarzfischer, Dagmar Glatz, Margit Nuetzel, Daniel Heudobler, MD, Sandra Pohl, Wolfgang Herr, MD, Gerhard Ehninger, MD, Claudia Erpelinck-Verschueren, B.Sc., Stanley van Herk, B.Sc., B.J. Wouters, Christian Thiede, MD, Ruud Delwel, PhD, Michael Rehli, PhD

Blood (2018) 132 (Supplement 1): 2608.

https://doi.org/10.1182/blood-2018-99-118521

Published: 2018

Journal Articles

Biomodulatory Metronomic Therapy Shows Remarkable Activity in Chemorefractory Multi-System Langerhans Cell Histiocytosis

Daniel Heudobler, MD, Klaus Rehe, MD PhD, Juergen Foell, MD, Selim Corbacioglu, MD, Gerhard Hildebrandt, MD, Wolfgang Herr, MD, Albrecht Reichle, MD, Martin Vogelhuber, MD

Blood (2016) 128 (22): 4254.

https://doi.org/10.1182/blood.V128.22.4254.4254

Published: 2016

Journal Articles

Somatic Genetic and Epigenetic Architecture of Myelodysplastic Syndromes Arising from GATA2 Deficiency

Victor Bengt Pastor Loyola, MSc, Shinsuke Hirabayashi, MD, Sandra Pohl, PhD, Emilia J Kozyra, MSc, Albert Catala, MD, Barbara De Moerloose, MD PhD, Michael Dworzak, MD, Henrik Hasle, MD, Riccardo Masetti, MD, Markus Schmugge, MD, Owen Smith, Jan Starý, MD, Marek Ussowicz, MD, Marry M. van den Heuvel-Eibrink, MD PhD, Ester Mejstrikova, MD PhD, Ulrich Salzer, MD, Michael Lübbert, MD, Daniel Heudobler, MD, David Betts, MD, Jose Cervera, MD, Gudrun Göhring, MD, Oskar A. Haas, Olga Haus, MD, Kyra Michalova, PhD DSc, Francesco Pasquali, MD, Joelle Tchinda, MD, Nadine van Roy, MD, Brigitte Schlegelberger, MD Prof., H. Berna Beverloo, PhD, Peter Noellke, MSc, Ayami Yoshimi, MD, Franco Locatelli, Prof, MD PhD, Brigitte Strahm, MD, Jaroslaw P. Maciejewski, MD PhD, Michael Rehli, PhD, Charlotte M Niemeyer, Prof, MD, Marcin W Wlodarski, MD

Blood (2015) 126 (23): 299.

https://doi.org/10.1182/blood.V126.23.299.299

Published: 2015

Journal Articles

Telomere shortening in enterocytes of patients with uncontrolled acute intestinal graft-versus-host disease

Sebastian Hummel, Mónica S. Ventura Ferreira, Daniel Heudobler, Elisabeth Huber, Dirk Fahrenkamp, Felix Gremse, Karin Schmid, Gerhard Müller-Newen, Patrick Ziegler, Edgar Jost, Maria A. Blasco, Tim H. Brümmendorf, Ernst Holler, Fabian Beier

Blood (2015) 126 (22): 2518–2521.

https://doi.org/10.1182/blood-2015-03-633289

Published: 2015

Includes: Supplemental data

Journal Articles

Enterocytes Of Patients With Uncontrolled Acute Graft Versus Host Disease Of The Gut Undergo Massive Telomere Shortening Compared To Unaffected Controls

Sebastian Hummel, Daniel Heudobler, MD, Elisabeth Huber, MD, Monica S Ventura Ferreira, PhD, Dirk Fahrenkamp, Karin Schmid, MD, Felix Gremse, PhD, Gerhard Müller-Newen, PhD, Patrick Ziegler, PhD, Edgar Jost, MD, Tim H. Brümmendorf, MD, Ernst Holler, MD, PhD, Fabian Beier, MD

Blood (2013) 122 (21): 4467.

https://doi.org/10.1182/blood.V122.21.4467.4467

Published: 2013

NARROW

A Phase 1, Open-Label, Dose Escalation and Dose Expansion Study of Cln-049 for the Treatment of Acute Myeloid Leukemia Patients with Measurable Residual Disease

Analysis of the Impact of Body Mass Index (BMI) on the Durability of Response in Patients with Aplastic Anemia Treated with Weight-Adjusted Horse Anti-Thymocyte Globulin (hATG)

Mutation Profile of PPM1D and TP53 in Patients with Myelodysplastic Syndromes and Complex Chromosome Abnormalities

Low-Dose Azacitidine, Pioglitazone and All-Trans Retinoic Acid Versus Standard-Dose Azacitidine in Patients ≥ 60 Years with Acute Myeloid Leukemia Refractory to Standard Induction Chemotherapy (AMLSG 26-16/AML-ViVA): Results of the Safety Run-in Phase I

Molecular Profile and Cytomorphological Manifestation of Isolated Y Loss in Myelodysplastic Syndromes

Integrated Analysis of Global DNA Methylation and Transcription Reveals a Leukemia Subtype with Extreme Hypermethylation Associated with Silencing of Regulators of Differentiation

Biomodulatory Metronomic Therapy Shows Remarkable Activity in Chemorefractory Multi-System Langerhans Cell Histiocytosis

Somatic Genetic and Epigenetic Architecture of Myelodysplastic Syndromes Arising from GATA2 Deficiency

Telomere shortening in enterocytes of patients with uncontrolled acute intestinal graft-versus-host disease

Enterocytes Of Patients With Uncontrolled Acute Graft Versus Host Disease Of The Gut Undergo Massive Telomere Shortening Compared To Unaffected Controls

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only